On Friday, 17th April 2026, KAVI-ICR had the privilege of hosting Dr Dipesh Solanky, MD, for a guest seminar titled:
“Molecular Diagnostics for HPV and the Role of Amplicon Sequencing toward Cervical Cancer Elimination.”
This week, KAVI–Institute of Clinical Research (KAVI-ICR), University of Nairobi, in partnership with ClinWin Research Services, is hosting a high-impact Clinical Trial Monitoring Course in Nairobi, bringing together early-career and experienced professionals from across the region. The course is part of a long-standing collaboration between KAVI-ICR and ClinWin focused on strengthening Africa’s clinical research ecosystem through practical, skills-based training and mentorship.
KAVI-Institute of Clinical Research (KAVI-ICR) continues to demonstrate leadership in laboratory biosafety and biosecurity through its participation in the CEPI ISO 35001 Implementation Project. Representatives from KAVI-ICR, including its founder, Professor Omu Anzala, and Laboratory Technologist Dennis Chalo, attended a high-level coordination meeting at the National Institute for Communicable Diseases in Johannesburg from March 30 to April 1, 2026.
KAVI-Institute of Clinical Research is proud to highlight the participation of our Postdoctoral Research Fellow, Dr Zipporah Richard, in the One Health Early Career Champions Programme held in Helsinki, Finland.
The KAVI-Institute of Clinical Research (KAVI-ICR) recently visited the Microsoft AI for Good Lab in Nairobi. The meeting provided an opportunity to exchange ideas at the intersection of artificial intelligence and public health research and to understand each other’s work better.
KAVI-ICR hosted Dr Huwaida Bulhan, Africa Region Lead at Sanofi, for a courtesy visit focused on strengthening academia–industry collaboration.
The KAVI-Institute of Clinical Research (KAVI-ICR) is proud to announce that Project SeriHealth, a collaborative initiative with Silk Origin Limited, has been awarded 2nd place at the University of Nairobi Research Innovation Week Awards in the Innovations and Industrial Linkages category.
KAVI-Institute of Clinical Research (KAVI-ICR) is proud to share insights from AfriBOP 2026, held from 16–20 March in Cape Town, which celebrated a decade of transformative impact in building Africa’s research capacity.
From 10–12 March 2026, researchers from KAVI-Institute of Clinical Research (KAVI-ICR) actively participated in the HIV Vaccine Science Academy held in Dar es Salaam, Tanzania. The academy, organized by the International AIDS Society, brought together early-career scientists and leading global experts to explore the latest advances in HIV vaccine research.
As the world marks World Tuberculosis Day on March 24th, KAVI-Institute of Clinical Research reaffirms its commitment to raising awareness, promoting early diagnosis, and supporting effective treatment of tuberculosis (TB). Tuberculosis remains one of the world’s deadliest infectious diseases, with millions of new cases reported annually. Despite progress, global reductions in TB incidence remain below targets, highlighting the urgent need for intensified action.
